Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosis

Woudstra, P; Kalkman, DN; Beijk, MA; Klomp, M; Damman, P; Koch, KT; Henriques, JPS; Baan, J; Vis, MM; Piek, JJ; Tijssen, JGP; de Winter, RJ

de Winter, RJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Room B2-137,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018; 91 (7): 1212

Abstract

ObjectivesTo assess the long-term safety and clinical efficacy of the Genous endothelial progenitor cell capturing stent (ECS) compared with the TAXUS......

Full Text Link